PRIMECAP Management's position in Boston Scientific is currently worth $1.58B. That's 0.97% of their equity portfolio (23rd largest holding). The first Boston Scientific trade was made in Q1 2013. Since then PRIMECAP Management bought shares sixteen more times and sold shares on 36 occasions. The stake costed the investor $399M, netting the investor a gain of 296% so far.
E. Ohman J or Asset Management AB boosted its holdings in Boston Scientific Corporation (NYSE: BSX) by 42.0% during the undefined quarter, according to the c...
Congress Asset Management Co. cut its holdings in Boston Scientific Corporation (NYSE: BSX) by 2.0% during the fourth quarter, according to the company in it...
Avity Investment Management Inc. purchased a new position in Boston Scientific Corporation (NYSE: BSX) during the third quarter, according to the company in ...
Cim Investment Management Inc. trimmed its holdings in shares of Boston Scientific Corporation (NYSE: BSX) by 50.6% in the third quarter, according to its mo...